Hepregen Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Hepregen General Information

Description

Developer of bio-engineering technology designed to transform safety assessment and drug development. The company's technology is used to build a bio-engineered micro-liver platform for use in a range of applications, including metabolite identification, toxicity screening, clearance, drug-drug interactions and transporter involvement, enabling physicians to have validated pharmaceuticals products.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 200 Boston Avenue
  • Suite 1500
  • Medford, MA 02155
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Vertical(s)
Corporate Office
  • 200 Boston Avenue
  • Suite 1500
  • Medford, MA 02155
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hepregen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 06-Nov-2015 Completed Generating Revenue
9. Grant 27-Jun-2012 Completed Generating Revenue
8. Grant 25-May-2011 Completed Startup
7. Accelerator/Incubator 01-Jan-2011 Completed Startup
6. Grant 13-Jan-2010 Completed Startup
5. Grant 01-Sep-2009 Completed Startup
4. Grant 01-Mar-2009 Completed Startup
3. Early Stage VC (Series A) 25-Feb-2009 Completed Startup
2. Spin-Off 02-Sep-2008 Completed Startup
1. Grant 01-Sep-2008 $200K Completed Startup
To view Hepregen’s complete valuation and funding history, request access »

Hepregen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Hepregen’s complete cap table history, request access »

Hepregen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of bio-engineering technology designed to transform safety assessment and drug development. The company's tech
Biotechnology
Medford, MA

Cambridge, MA
 

Incheon, South Korea
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hepregen Competitors (22)

One of Hepregen’s 22 competitors is Nabla Bio, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nabla Bio Venture Capital-Backed Cambridge, MA
Samsung Bioepis Corporate Backed or Acquired Incheon, South Korea
Biocon Biologics Formerly PE-Backed Bengaluru, India
Generate Biomedicines Formerly VC-backed Somerville, MA
Siegfried Holding Corporation Zofingen, Switzerland
You’re viewing 5 of 22 competitors. Get the full list »

Hepregen Patents

Hepregen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20130266939-A1 Systems and methods for studying inflammation-drug interactions Inactive 12-Mar-2012
WO-2013138348-A1 Systems and methods for studying inflammation-drug interactions Inactive 12-Mar-2012
WO-2012099787-A1 Systems and methods for micro-contact stamping Inactive 21-Jan-2011 C12M33/02

Hepregen Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Battelle Ventures Venture Capital Minority
Catalyst Health Ventures Venture Capital Minority
Innovation Valley Partners Venture Capital Minority
Springboard Enterprises Accelerator/Incubator Minority
US National Science Foundation Accelerator/Incubator
To view Hepregen’s complete investors history, request access »

Hepregen FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process